Arbutus Biopharma(DE:I9DN)
€3.45+0.06 (+1.80%)
DE:I9DN
Arbutus Biopharma earnings date
€3.45
At close:+0.06 (+1.80%)
Arbutus Biopharma (I9DN) Q4 2019 Earnings Report
1 Followers
DE:I9DN Q4 2019 EPS Results
- Actual EPS
- -EUR 0.41
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.33
DE:I9DN Q4 2019 Revenue Results
- Actual Revenue
- EUR 1.45M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -3.58%
Earnings Announcement Details
- Quarter
- Q4 2019
- Date
- 03/05/2020
- Time
- Before Open
- Conference Call
- Thursday, March 5, 2020
DE:I9DN Upcoming Earnings
Arbutus Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:I9DN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.02- | -0.01 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.020.27 | -0.04 | 850.00% (+0.30) | |
| Aug 12, 2026 | 2026 (Q2) | -0.02-0.03 | 0.01 | -400.00% (-0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.030.78 | -0.12 | 769.23% (+0.90) | |
| Mar 23, 2026 | 2025 (Q4) | -0.03-0.01 | -0.06 | 85.71% (+0.05) | |
| Nov 13, 2025 | 2025 (Q3) | -0.03-0.04 | -0.09 | 60.00% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.040.01 | -0.1 | 109.09% (+0.11) | |
| May 14, 2025 | 2025 (Q1) | -0.09-0.12 | -0.09 | -30.00% (-0.03) | |
| Mar 27, 2025 | 2024 (Q4) | -0.07-0.06 | -0.11 | 41.67% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | -0.08-0.09 | -0.11 | 16.67% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
